This brand name is authorized in United States. It is also authorized in Austria, Canada, Cyprus, Estonia, Hong Kong SAR China, Ireland, Lithuania, Malta, New Zealand, Poland, Romania, Singapore, Spain, UK.
The drug INTRALIPID contains one active pharmaceutical ingredient (API):
1
|
UNII
241ATL177A - SOYBEAN OIL
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
B05BA02 | Fat emulsions | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BA Solutions for parenteral nutrition |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
CA | Health Products and Food Branch | 02065673 |
EE | Ravimiamet | 1009280, 1066687, 1066698, 1776809 |
ES | Centro de información online de medicamentos de la AEMPS | 43165, 61534 |
GB | Medicines & Healthcare Products Regulatory Agency | 308369, 308370, 308372, 308374, 308375, 76275, 76279, 76283, 76287, 76291 |
HK | Department of Health Drug Office | 35420, 35421 |
LT | Valstybinė vaistų kontrolės tarnyba | 1008223, 1008224, 1008225, 1008226, 1011905, 1034424, 1034425, 1086407 |
MT | Medicines Authority | MA1123/02001 |
NZ | Medicines and Medical Devices Safety Authority | 1241, 1242, 1243 |
PL | Rejestru Produktów Leczniczych | 100031894, 100031902 |
RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W57683010, W57683011, W57683012, W57683013 |
SG | Health Sciences Authority | 05269P |
US | FDA, National Drug Code | 0338-0518, 0338-0519, 0338-0520, 51662-1333 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.